Physician profile
Erin Evans
NPI 1952528036
$2,591.11
in general payments reported to CMS, 2019-2025
30 companies · $701 in 2025
The $701 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $118 · 2021: $382 · 2022: $212 · 2023: $435 · 2024: $506 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.39 |
| Education | $274.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $458.92 | 2021-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $290.60 | 2019-2025 | |
| Abbvie INC. | $254.35 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $233.38 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $202.15 | 2022-2025 | |
| Coopersurgical, INC. | $120.21 | 2023-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Pfizer INC. | $93.18 | 2019-2024 | |
| Exeltis, USA INC. | $82.88 | 2022-2023 | Slynd |
| Hologic Sales and Service, LLC | $82.12 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Coolseal Generator |
| Organon LLC | $78.24 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $72.01 | 2021 | |
| Biogen, INC. | $68.99 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $68.75 | 2022 | |
| Novo Nordisk INC | $59.68 | 2025 | Wegovy |
| Therapeuticsmd, INC. | $57.54 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $55.43 | 2024 | |
| Conmed Corporation | $51.60 | 2024-2025 | Airseal |
| Lilly USA, LLC | $38.04 | 2025 | Zepbound, Mounjaro |
| Medtronic, INC. | $29.41 | 2024 | V-Loc 180 |
| Daiichi Sankyo INC. | $26.88 | 2021 | |
| Allergan, INC. | $22.28 | 2019 | |
| Meditrina | $19.13 | 2022 | |
| Minerva Surgical, INC | $18.10 | 2025 | |
| Karl Storz Endoscopy-America | $17.81 | 2019 | |
| Si-Bone, INC. | $17.34 | 2024 | |
| Alydia Health | $16.05 | 2021 | |
| Avion Pharmaceuticals | $15.57 | 2021 | |
| Pelvital USA, INC. | $14.49 | 2025 | |
| Agile Therapeutics, INC. | $13.35 | 2021 | |
| Duchesnay USA Incorporated | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.